Sentences with phrase «melanoma research center»

The key to reaching college kids might be to catch them when they're younger, said Ashani Weeraratna, a professor with the Melanoma Research Center at the Wistar Institute in Philadelphia.

Assistant Professor, Molecular & Cellular Oncogenesis Program Member, The Wistar Institute Melanoma Research Center

Caspar Wistar Professor in Melanoma Research Director, The Wistar Institute Melanoma Research Center Professor, Molecular & Cellular Oncogenesis Program

Wistar launched the The Wistar Melanoma Research Center under the direction of Meenhard Herlyn, D.V.M., D.Sc., in an effort to fast track basic research that could lead to defining new therapies.

Assistant Professor, Molecular and Cellular Oncogenesis Program Member, The Wistar Institute Melanoma Research Center

Ira Brind Professor Professor and Co-Program Leader, Immunology, Microenvironment and Metastasis Program Member, The Wistar Institute Melanoma Research Center

Scientists at The Wistar Institute Melanoma Research Center have made huge strides in understanding the biology that underlies this disease, from basic genetics to the study of melanoma cell interaction with the microenvironment and new concepts that describe the stem cell - like abilities of melanoma to evade treatment.

Caspar Wistar Professor in Melanoma Research Director, The Wistar Institute Melanoma Research Center Professor, Molecular and Cellular Oncogenesis Program

Keiran S. Smalley, Ph.D., scientific director of the Melanoma Research Center of Excellence, and his team began investigating this pathway in 2010 and discovered the best way to block its ability to promote cancer cell growth was with combined inhibitor therapy.

According to Herlyn, Wistar's Melanoma Research Center is working with their clinical partners to develop a clinical trial to apply their research findings to patients with advanced melanoma.

«We have found that the individual cells within melanoma tumors are not all identical, and tumors contain a sub-population of cells that are inherently drug resistant, which accounts for the fact that advanced melanoma tumors return no matter how much the tumor is depleted,» said Meenhard Herlyn, D.V.M., D.Sc., professor and director of Wistar's Melanoma Research Center.

«Our findings provide a possible flanking strategy to counteract the ability of melanoma cells to re-wire their signaling networks,» said co-coresponding author Meenhard Herlyn, Caspar Wistar Professor in Melanoma Research and director of the Melanoma Research Center at The Wistar Institute.

Not exact matches

Memorial donations may be made in honour of Shawn Price to the Cancer Center of Melanoma Research at CPMC Sutter Health Foundation: www.cpmc.org/giving.

Research teams focused on both cutaneous and uveal melanoma are fast - tracking discoveries into the clinical setting, and bringing novel therapeutic options to patients in the Philadelphia region,» said Karen Knudsen, Director of the Sidney Kimmel Cancer Center.

«Dr. Aplin's major research advance is part of a larger effort by the Sidney Kimmel Cancer Center to develop new strategies for treating melanoma.

Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet - B (UVB) light delayed melanoma onset in a mouse model of the disease, according to data from a team at The Ohio State University Comprehensive Cancer Center Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

The second report, identifies the immunotherapy resistance mechanism in melanoma cells, is from a group led by Kai Wucherpfennig, MD, PhD, director of Dana - Farber's Center for Cancer Immunotherapy Research, and Shirley Liu, PhD, of Dana - Farber.

Researchers at the University of Chicago are studying kidney cancer, researchers at the Mayo Clinic are testing this therapy against colon cancer, and researchers at the Arizona Cancer Center are continuing the research on melanoma.

As a tumor immunologist at UCLA's Jonsson Comprehensive Cancer Center, Dr. Ribas specializes in the research and treatment of melanoma, the deadliest form of skin cancer.

Results of the international trial, led by principal investigator Jeffrey S. Weber, MD, PhD, the Laura and Isaac Perlmutter Professor of Oncology, deputy director of Perlmutter Cancer Center, and co-leader of its Melanoma Research Program, were published in November 2017 in The New England Journal of Medicine.

As part of a nationally recognized cancer research and treatment center, the Melanoma / Skin Cancer Program conducts innovative research to understand how melanoma develops, and how to better prevent and tMelanoma / Skin Cancer Program conducts innovative research to understand how melanoma develops, and how to better prevent and tmelanoma develops, and how to better prevent and treat it.

Dr. Marlin worked as the Director of Medical Education at the with Dr. Dean Ornish's Preventive Medicine Research Institute and served as the Associate Director of the Northern California Melanoma Center at St. Mary's Medical Center in San Francisco.

«Melanoma is a serious disease that can advance and spread to other parts of the body, where it becomes difficult to treat,» said Dr. Karen Midthun, director of the FDA's Center for Biologics Evaluation and Research.